CIPROFLOXACIN HYDROCHLORIDE

Post-LOE

ciprofloxacin hydrochloride

Molecular Devices

ANDAORALTABLET

Approved

Nov 2004

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

CIPROFLOXACIN HYDROCHLORIDE (ciprofloxacin hydrochloride) by Molecular Devices is [see microbiology ( )]. Approved for plague, including pneumonic, septicemic plague and 40 more indications. First approved in 2004.

Drug data last refreshed 22h ago

Mechanism of Action

[see Microbiology ( )].

Indications (40)

plague including pneumonic septicemic plague

Worked on CIPROFLOXACIN HYDROCHLORIDE at Molecular Devices? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.